2,501
Views
18
CrossRef citations to date
0
Altmetric
Review

Drug delivery for bioactive polysaccharides to improve their drug-like properties and curative efficacy

, , , &
Pages 70-80 | Received 12 Sep 2017, Accepted 20 Oct 2017, Published online: 10 Nov 2017

References

  • Agrawal M, Ajazuddin Tripathi DK, et al. (2017). Recent advancements in liposomes targeting strategies to cross blood–brain barrier (BBB) for the treatment of Alzheimer's disease. J Control Release 260:61–77.
  • Alam F, Al-Hilal TA, Chung SW, et al. (2014). Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid. Biomaterials 35:6543–52.
  • Alhilal TA, Park J, Alam F, et al. (2014). Oligomeric bile acid-mediated oral delivery of low molecular weight heparin. J Control Release 175:17–24.
  • Amagase H, Sun B, Borek C. (2009). Lycium barbarum (goji) juice improves in vivo antioxidant biomarkers in serum of healthy adults. Nutr Res 29:19–25.
  • Balakrishnan A, Polli JE. (2006). Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target. Mol Pharm 3:223–30.
  • Bao XF, Wang XS, Dong Q, et al. (2002). Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry 59:175–81.
  • Bo R, Ma X, Feng Y, et al. (2015). Optimization on conditions of Lycium barbarum polysaccharides liposome by RSM and its effects on the peritoneal macrophages function. Carbohydr Polym 117:215–22.
  • Bo R, Zheng S, Xing J, et al. (2016). The immunological activity of Lycium barbarum polysaccharides liposome in vitro and adjuvanticity against PCV2 in vivo. Int J Biol Macromol 85:294–301.
  • Böttger R, Knappe D, Hoffmann R. (2016). Readily adaptable release kinetics of prodrugs using protease-dependent reversible PEGylation. J Control Release 230:88–94.
  • Chae SY, Jang MK, Nah JW. (2005). Influence of molecular weight on oral absorption of water soluble chitosans. J Control Release 102:383–94.
  • Chang JS, Kuo HP, Chang KL, Kong ZL. (2015). Apoptosis of hepatocellular carcinoma cells induced by nanoencapsulated polysaccharides extracted from Antrodia camphorata. PLoS One 10:e0136782.
  • Chen MC, Wong HS, Lin KJ, et al. (2009). The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin. Biomaterials 30:6629–37.
  • Chen Y, Yao F, Ming K, et al. (2016). Polysaccharides from traditional Chinese medicines: extraction, purification, modification, and biological activity. Molecules 21:1705.
  • Davis ME, Chen ZG, Shin DM. (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:771–82.
  • Dong Q, Lin X, Shen L, Feng Y. (2016). The protective effect of herbal polysaccharides on ischemia-reperfusion injury. Int J Biol Macromol 92:431–40.
  • Dong YL, Sang KK, Kim YS, et al. (2007). Suppression of angiogenesis and tumor growth by orally active deoxycholic acid-heparin conjugate. J Control Release 118:310–7.
  • Dou Y, Hynynen K, Allen C. (2017). To heat or not to heat: challenges with clinical translation of thermosensitive liposomes. J Control Release 249:63–73.
  • Ernst B, Magnani JL. (2009). From carbohydrate leads to glycomimetic drugs. Nat Rev Drug Discov 8:661–77.
  • Fan Y, Lin M, Zhang W, et al. (2013a). Liposome can improve the adjuvanticity of astragalus polysaccharide on the immune response against ovalbumin. Int J Biol Macromol 60:206–12.
  • Fan Y, Liu J, Wang D, et al. (2013b). The preparation optimization and immune effect of epimedium polysaccharide-propolis flavone liposome. Carbohydr Polym 94:24–30.
  • Fan Y, Ma X, Hou W, et al. (2016a). The adjuvanticity of ophiopogon polysaccharide liposome against an inactivated porcine parvovirus vaccine in mice. Int J Biol Macromol 82:264–72.
  • Fan Y, Ma X, Ma L, et al. (2016b). Antioxidative and immunological activities of ophiopogon polysaccharide liposome from the root of Ophiopogon japonicus. Carbohydr Polym 135:110–20.
  • Fan Y, Ma X, Zhang J, et al. (2015a). Ophiopogon polysaccharide liposome can enhance the non-specific and specific immune response in chickens. Carbohydr Polym 119:219–27.
  • Fan Y, Ren M, Hou W, et al. (2015b). The activation of Epimedium polysaccharide-propolis flavone liposome on Kupffer cells. Carbohydr Polym 133:613–23.
  • Fan Y, Song X, Gao Y, et al. (2014). Preparation and optimization of ophiopogon polysaccharide liposome and its activity on Kupffer cells. Int J Pharm 477:421–30.
  • Fan YP, Wang DY, Hu YL, et al. (2011). Preparation condition optimization of astragalus polysaccharide liposome by orthogonal test. Chin Tradit Herb Drugs 42:470–3.
  • Fontana A, Spolaore B, Mero A, Veronese FM. (2008). Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase. Adv Drug Deliv Rev 60:13–28.
  • Greenwald RB, Gilbert CW, Pendri A, et al. (1996). Drug delivery systems: water soluble Taxol 2′-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness. J Med Chem 39:424–31.
  • Hérault JP, Bernat A, Roye F, et al. (2002). Pharmacokinetics of new synthetic heparin mimetics. Thromb Haemost 87:985.
  • Hoffart V, Lamprecht A, Maincent P, et al. (2006). Oral bioavailability of a low molecular weight heparin using a polymeric delivery system. J Control Release 113:38–42.
  • Huang Y, Liu Z, Bo R, et al. (2016). The enhanced immune response of PCV-2 vaccine using Rehmannia glutinosa polysaccharide liposome as an adjuvant. Int J Biol Macromol 86:929–36.
  • Huang Y, Washio Y, Hara M, et al. (1996). Simultaneous determination of dermatan sulfate and oversulfated dermatan sulfate in plasma by high-performance liquid chromatography with postcolumn fluorescence derivatization. Anal Biochem 240:227–34.
  • Huang Y, Wu C, Liu Z, et al. (2014). Optimization on preparation conditions of Rehmannia glutinosa polysaccharide liposome and its immunological activity. Carbohydr Polym 104:118–26.
  • Hwang SR, Seo DH, Al-Hilal TA, et al. (2012). Orally active desulfated low molecular weight heparin and deoxycholic acid conjugate, 6ODS-LHbD, suppresses neovascularization and bone destruction in arthritis. J Control Release 163:374–84.
  • Juvekar S, Kathpalia H. (2017). Solvent removal precipitation based in situ forming implant for controlled drug delivery in periodontitis. J Control Release 251:75–81.
  • Kandrotas RJ. (1992). Heparin pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 22:359–74.
  • Kang JS, Deluca PP, Lee KC. (2009). Emerging PEGylated drugs. Expert Opin Emerg Drugs 14:363–80.
  • Karoli T, Liu L, Fairweather JK, et al. (2005). Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88). J Med Chem 48:8229–36.
  • Khaw BA, Dasilva J, Hartner WC. (2007). Cytoskeletal-antigen specific immunoliposome-targeted in vivo preservation of myocardial viability. J Control Release 120:35–40.
  • Khaw BA, Torchilin VP, Vural I, Narula J. (1995). Plug and seal: prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes. Nat Med 1:1195–8.
  • Kimura M, Maeshima T, Kubota T, et al. (2016). Absorption of orally administered hyaluronan. J Med Food 19:1172–9.
  • Kong ZL, Chang JS, Chang KLB. (2013). Antiproliferative effect of Antrodia camphorata polysaccharides encapsulated in chitosan–silica nanoparticles strongly depends on the metabolic activity type of the cell line. J Nanopart Res 15:1–13.
  • Koyama Y, Miyagawa T, Kawaide A, Kataoka K. (1996). Receptor-mediated absorption of high molecular weight dextrans from intestinal tract. J Control Release 41:171–6.
  • Kusaykin M, Bakunina I, Sova V, et al. (2008). Structure, biological activity, and enzymatic transformation of fucoidans from the brown seaweeds. Biotechnol J 3:904–15.
  • Lamprecht A, Koenig P, Ubrich N, et al. (2006). Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells. Nanotechnology 17:3673.
  • Lee Y, Nam JH, Shin HC, Byun Y. (2001). Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent. Circulation 104:3116–20.
  • Levchenko TS, Hartner WC, Torchilin VP. (2012). Liposomes for cardiovascular targeting. Ther Deliv 3:501–14.
  • Li DY. (2005). Studies of Epimedium polysaccharide on separation, purification, structure and immunocompetence [Master degree thesis]. Zhengzhou University.
  • Li PL, Li CX, Xue YT, et al. (2013). An HPLC method for microanalysis and pharmacokinetics of marine sulfated polysaccharide PSS-loaded poly lactic-co-glycolic acid (PLGA) nanoparticles in rat plasma. Mar Drugs 11:1113–25.
  • Li PL, Xu XL, Li CX, et al. (2011). Study on preparation, release in vitro and pharmacodynamics of the oral propylene glycol alginate sodium sulfate (PSS) nanoparticles. Chin J Mar Drugs 30:19–24.
  • Lin X, Wang S, Jiang Y, et al. (2010a). Poly(ethylene glycol)-radix Ophiopogonis polysaccharide conjugates: preparation, characterization, pharmacokinetics and in vitro bioactivity. Eur J Pharm Biopharm 76:230–7.
  • Lin X, Wang Z, Sun G, et al. (2010b). A sensitive and specific HPGPC-FD method for the study of pharmacokinetics and tissue distribution of Radix Ophiopogonis polysaccharide in rats. Biomed Chromatogr 24:820–5.
  • Lin X, Wang ZJ, Huang F, et al. (2011a). Long-circulating delivery of bioactive polysaccharide from radix ophiopogonis by PEGylation. Int J Nanomed 6:2865–72.
  • Lin X, Wang ZJ, Wang S, et al. (2011b). Comparison of tissue distribution of a PEGylated Radix Ophiopogonis polysaccharide in mice with normal and ischemic myocardium. Eur J Pharm Biopharm 79:621–6.
  • Lin X, Xu DS, Feng Y, Shen L. (2005). Determination of Ophiopogon japonicus polysaccharide in plasma by HPLC with modified postcolumn fluorescence derivatization. Anal Biochem 342:179–85.
  • Liu Z, Ma X, Deng B, et al. (2015). Development of liposomal Ganoderma lucidum polysaccharide: formulation optimization and evaluation of its immunological activity. Carbohydr Polym 117:510–7.
  • Liu Z, Xing J, Huang Y, et al. (2016a). Activation effect of Ganoderma lucidum polysaccharides liposomes on murine peritoneal macrophages. Int J Biol Macromol 82:973–8.
  • Liu Z, Xing J, Zheng S, et al. (2016b). Ganoderma lucidum polysaccharides encapsulated in liposome as an adjuvant to promote Th1-bias immune response. Carbohydr Polym 142:141–8.
  • Luo L, Zheng S, Huang Y, et al. (2016). Preparation and characterization of Chinese yam polysaccharide PLGA nanoparticles and their immunological activity. Int J Pharm 511:140–50.
  • Manivasagan P, Bharathiraja S, Bui NQ, et al. (2016). Doxorubicin-loaded fucoidan capped gold nanoparticles for drug delivery and photoacoustic imaging. Int J Biol Macromol 91:578–88.
  • Mehvar R, Robinson MA, Reynolds JM. (1994). Molecular weight dependent tissue accumulation of dextrans: in vivo studies in rats. J Pharm Sci 83:1495–9.
  • Mehvar R, Shepard TL. (1992). Molecular-weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats. J Pharm Sci 81:908–12.
  • Niu Y, Wang H, Xie Z, et al. (2011). Structural analysis and bioactivity of a polysaccharide from the roots of Astragalus membranaceus (Fisch) Bge. var. mongolicus (Bge.) Hsiao. Food Chem 128:620–6.
  • Pasut G, Veronese FM. (2007). Polymer–drug conjugation, recent achievements and general strategies. Prog Polym Sci 32:933–61.
  • Pasut G, Veronese FM. (2009). PEGylation for improving the effectiveness of therapeutic biomolecules. Drugs Today 45:687–95.
  • Paulis LE, Geelen T, Kuhlmann MT, et al. (2012). Distribution of lipid-based nanoparticles to infarcted myocardium with potential application for MRI-monitored drug delivery. J Control Release 162:276–85.
  • Petros RA, Desimone JM. (2010). Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9:615–27.
  • Rice PJ, Adams EL, Ozment-Skelton T, et al. (2005). Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther 314:1079–86.
  • Samama MM, Gerotziafas GT. (2000). Comparative pharmacokinetics of LMWHs. Semin Thromb Hemost 26 Suppl 1:31–8.
  • Seymour LW. (1992). Passive tumor targeting of soluble macromolecules and drug conjugates. Crit Rev Ther Drug Carrier Syst 9:135–87.
  • Shi LL, Li Y, Wang Y, Feng Y. (2015a). MDG-1, an Ophiopogon polysaccharide, regulate gut microbiota in high-fat diet-induced obese C57BL/6 mice. Int J Biol Macromol 81:576–83.
  • Shi X, Lin X, Yao C, et al. (2015b). Injectable long-acting in situ forming systems for Radix Ophiopogonis polysaccharide. Int J Biol Macromol 72:553–9.
  • Shi X, Lin X, Zheng X, et al. (2014). Injectable long-acting systems for Radix Ophiopogonis polysaccharide based on mono-PEGylation and in situ formation of a PLGA depot. Int J Nanomed 9:5555–63.
  • Shoaib M, Shehzad A, Omar M, et al. (2016). Inulin: properties, health benefits and food applications. Carbohydr Polym 147:444–54.
  • Suk JS, Xu Q, Kim N, et al. (2016). PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev 99:28–51.
  • Sun G, Lin X, Shen L, et al. (2013). Mono-PEGylated radix ophiopogonis polysaccharide for the treatment of myocardial ischemia. Eur J Pharm Sci 49:629–36.
  • Sun W, Hu W, Meng K, et al. (2016a). Activation of macrophages by the ophiopogon polysaccharide liposome from the root tuber of Ophiopogon japonicus. Int J Biol Macromol 91:918–25.
  • Sun W, Saldaña MD, Fan L, et al. (2016b). Sulfated polysaccharide heparin used as carrier to load hydrophobic lappaconitine. Int J Biol Macromol 84:275–80.
  • Takahama H, Shigematsu H, Asai T, et al. (2013). Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat model. Cardiovasc Drugs Ther 27:125–32.
  • Tan W, Yu KQ, Liu YY, et al. (2012). Anti-fatigue activity of polysaccharides extract from Radix Rehmanniae Preparata. Int J Biol Macromol 50:59–62.
  • Thakur RR, McMillan HL, Jones DS. (2014). Solvent induced phase inversion-based in situ forming controlled release drug delivery implants. J Control Release 176:8–23.
  • Tomita M, Miwa M, Ouchi S, et al. (2009). Nonlinear intestinal absorption of (1→3)-beta-d-glucan caused by absorptive and secretory transporting system. Biol Pharm Bull 32:1295–7.
  • Tomoda M, Miyamoto H, Shimizu N. (1994). Structural features and anti-complementary activity of rehmannan SA, a polysaccharide from the root of Rehmannia glutinosa. Chem Pharm Bull 42:1666–8.
  • Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–60.
  • Venturoli D, Rippe B. (2005). Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am J Physiol Renal Physiol 288:F605–13.
  • Wang J, Zhang Y, Yuan Y, Yue T. (2014). Immunomodulatory of selenium nano-particles decorated by sulfated Ganoderma lucidum polysaccharides. Food Chem Toxicol 68:183–9.
  • Wang L, Lin X, Hong Y, et al. (2017). Hydrophobic mixed solvent induced PLGA-based in situ forming systems for smooth long-lasting delivery of Radix Ophiopogonis polysaccharide in rats. RSC Adv 7:5349–61.
  • Wang L, Yao C, Wu F, et al. (2015). Targeting delivery of Radix Ophiopogonis polysaccharide to ischemic/reperfused rat myocardium by long-circulating macromolecular and liposomal carriers. Int J Nanomed 10:5729–37.
  • Wu HT, He XJ, Hong YK, et al. (2010). Chemical characterization of Lycium barbarum polysaccharides and its inhibition against liver oxidative injury of high-fat mice. Int J Biol Macromol 46:540–3.
  • Xiao Y, Li P, Cheng Y, et al. (2014). Enhancing the intestinal absorption of low molecular weight chondroitin sulfate by conjugation with α-linolenic acid and the transport mechanism of the conjugates. Int J Pharm 465:143–58.
  • Xu DS, Feng Y, Lin X, et al. (2005). Isolation, purification and structural analysis of a polysaccharide MDG-1 from Ophiopogon japonicus. Acta Pharmaceut Sin 40:636–9.
  • Yamaoka T, Tabata Y, Ikada Y. (1994). Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J Pharm Sci 83:601–6.
  • Yang W, Wang Y, Li X, Yu P. (2015). Purification and structural characterization of Chinese yam polysaccharide and its activities. Carbohydr Polym 117:1021–7.
  • Yu Z, Guo F, Guo Y, et al. (2017). Optimization and evaluation of astragalus polysaccharide injectable thermoresponsive in-situ gels. PLoS One 12:e0173949.
  • Zheng NX, Zhang YX, Ge ZH, et al. (2000). Intestinal absorption of an acidic polysaccharide from Liuwei Dihuang decoction in mice. Chin Pharmacol Bull 16:403–5.
  • Zhou SS, Xu J, Zhu H, et al. (2016). Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction. Sci Rep 6:22474.